Related Experiment Video

Updated: Dec 8, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.7K

Policy in pediatric nephrology: successes, failures, and the impact on disparities

Jill R Krissberg1, Scott M Sutherland2, Lisa J Chamberlain3

  • 1Division of Nephrology, Department of Pediatrics, Stanford University School of Medicine, 300 Pasteur Drive, Room G-306, Stanford, 94304, CA, USA. jkrissbe@stanford.edu.

Pediatric Nephrology (Berlin, Germany)
|September 24, 2020
PubMed

Insights

Social determinants significantly impact pediatric kidney diseases, causing disparities. This review highlights initiatives to improve health equity for children with kidney disease.

Area of Science:

  • Pediatric Nephrology
  • Public Health
  • Health Equity

Background:

  • Pediatric nephrology has advanced child health policy for kidney diseases.
  • Significant social disparities persist for vulnerable children with kidney disease.
  • Multiple factors including genetics, environment, social risks, and healthcare access influence disease progression and outcomes.

Purpose of the Study:

  • To review global literature on social determinants of health in pediatric kidney disease.
  • To identify policy-based initiatives that address adverse social factors.
  • To promote greater health equity in pediatric kidney disease care.

Main Methods:

  • Comprehensive literature search on social determinants of health in pediatric kidney disease.
  • Analysis of studies examining risk factors and disparities.
  • Synthesis of policy-based interventions and their impact on equity.

Main Results:

  • Social determinants profoundly affect the emergence and progression of pediatric kidney disease.
  • Disparities in outcomes are linked to genetic, environmental, social, and healthcare access factors.
  • Policy initiatives show potential for mitigating adverse social factors.

Conclusions:

  • Addressing social determinants is crucial for reducing health inequities in pediatric kidney disease.
  • Targeted policy interventions are necessary to ensure equitable access to care and improve outcomes.
  • Further research and advocacy are needed to achieve health equity for all children with kidney disease.

Keywords:
AdvocacyHealth disparitiesMarginalized populationsPolicy

More Related Videos

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring07:35

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring

Published on: June 23, 2015

11.8K
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.3K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
131
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
108
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
165
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
144
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
242
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
172